RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Pediatrix Medical Group - Stock

Pediatrix Medical Group ROE 2024

Pediatrix Medical Group ROE

-0.07

Ticker

MD

ISIN

US58502B1061

WKN

A0RELL

In 2024, Pediatrix Medical Group's return on equity (ROE) was -0.07, a -195.63% increase from the 0.07 ROE in the previous year.

Pediatrix Medical Group Aktienanalyse

What does Pediatrix Medical Group do?

MEDNAX Inc. is an American company that provides medical services for newborns, children, and adults. The company was founded in 1979 in Florida and is headquartered in Sunrise, Florida. It is listed on the New York Stock Exchange and has an annual revenue of approximately $3.5 billion. MEDNAX's business model is to offer specialized medical services for newborns, children, and adults in hospitals, emergency rooms, and medical practices in the United States. The company operates a vertically integrated management structure that covers all aspects of healthcare, from clinical management to billing and coding. MEDNAX specializes in a wide range of specialties such as anesthesia, pediatrics, neonatology, intensive care, cardiology, radiology, and pathology. The company's history began in 1979 in Florida with the founding of the American Anesthesiology Practice (AAP). AAP has become a leading anesthesia service provider in Florida, serving hospitals, surgeons, and patients. In 1995, MEDNAX established the Florida Neonatology Practice (FNP) to provide specialized treatments for premature and sick newborns. In 2008, the company officially changed its name to MEDNAX. MEDNAX expanded through acquisitions of companies and practices. In 2010, MEDNAX acquired Pediatrix Medical Group, a leading provider of medical services for newborns, pregnant women, and women with high-risk pregnancies. In 2013, the company acquired Sheridan Healthcare, a market leader in anesthesia, radiology, and emergency medicine. In 2017, the company launched a new division in cardiology and acquired CardioSolutions, a company specializing in cardiac procedures. MEDNAX offers a wide range of medical services, divided into different divisions. These include neonatology, pediatrics, anesthesia, radiology, and pathology. The company also offers various products and services tailored to the specific needs of patients and physicians in the United States, such as cardiac services, coding and billing services, anesthesia devices, and preterm birth screening tests. Overall, MEDNAX is a leading provider of medical services in the United States, with a diverse range of specialties and services, and a growing presence through acquisitions. Pediatrix Medical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Pediatrix Medical Group's Return on Equity (ROE)

Pediatrix Medical Group's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Pediatrix Medical Group's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Pediatrix Medical Group's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Pediatrix Medical Group’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Pediatrix Medical Group Stock

What is the ROE (Return on Equity) of Pediatrix Medical Group this year?

The ROE of Pediatrix Medical Group this year is -0.07 undefined.

How has the Return on Equity (ROE) of Pediatrix Medical Group developed compared to the previous year?

The ROE of Pediatrix Medical Group has increased by -195.63% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Pediatrix Medical Group?

A high ROE indicates that Pediatrix Medical Group generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Pediatrix Medical Group?

A low ROE can indicate that Pediatrix Medical Group is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Pediatrix Medical Group affect the company?

A change in ROE (Return on Equity) of Pediatrix Medical Group can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Pediatrix Medical Group?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Pediatrix Medical Group?

Some factors that can influence Pediatrix Medical Group's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Pediatrix Medical Group pay?

Over the past 12 months, Pediatrix Medical Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pediatrix Medical Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Pediatrix Medical Group?

The current dividend yield of Pediatrix Medical Group is .

When does Pediatrix Medical Group pay dividends?

Pediatrix Medical Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Pediatrix Medical Group?

Pediatrix Medical Group paid dividends every year for the past 0 years.

What is the dividend of Pediatrix Medical Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Pediatrix Medical Group located?

Pediatrix Medical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pediatrix Medical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pediatrix Medical Group from 6/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did Pediatrix Medical Group pay the last dividend?

The last dividend was paid out on 6/26/2024.

What was the dividend of Pediatrix Medical Group in the year 2023?

In the year 2023, Pediatrix Medical Group distributed 0 USD as dividends.

In which currency does Pediatrix Medical Group pay out the dividend?

The dividends of Pediatrix Medical Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Pediatrix Medical Group stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Pediatrix Medical Group

Our stock analysis for Pediatrix Medical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pediatrix Medical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.